ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
170 hedge funds and large institutions have $300M invested in Antares Pharma, Inc. in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 70 increasing their positions, 42 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
3% less funds holding
Funds holding: 175 → 170 (-5)
16% less capital invested
Capital invested by funds: $356M → $300M (-$56.3M)
Holders
170
Holding in Top 10
2
Calls
$461K
Puts
$477K
Top Buyers
| 1 | +$2M | |
| 2 | +$1.82M | |
| 3 | +$1.57M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$1.27M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.26M |
Top Sellers
| 1 | -$7.36M | |
| 2 | -$3.07M | |
| 3 | -$2.15M | |
| 4 |
BAS
Brown Advisory Securities
Baltimore,
Maryland
|
-$1.2M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$861K |